JP2002523470A5 - - Google Patents

Download PDF

Info

Publication number
JP2002523470A5
JP2002523470A5 JP2000567236A JP2000567236A JP2002523470A5 JP 2002523470 A5 JP2002523470 A5 JP 2002523470A5 JP 2000567236 A JP2000567236 A JP 2000567236A JP 2000567236 A JP2000567236 A JP 2000567236A JP 2002523470 A5 JP2002523470 A5 JP 2002523470A5
Authority
JP
Japan
Prior art keywords
vaccine formulation
microparticles
nanoparticles
antigen
biodegradable polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000567236A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002523470A (ja
JP4601823B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IE1999/000086 external-priority patent/WO2000012124A1/en
Publication of JP2002523470A publication Critical patent/JP2002523470A/ja
Publication of JP2002523470A5 publication Critical patent/JP2002523470A5/ja
Application granted granted Critical
Publication of JP4601823B2 publication Critical patent/JP4601823B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000567236A 1998-09-01 1999-08-31 経口ワクチン組成物 Expired - Fee Related JP4601823B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9875998P 1998-09-01 1998-09-01
US60/098,759 1998-09-01
PCT/IE1999/000086 WO2000012124A1 (en) 1998-09-01 1999-08-31 Oral vaccine compositions

Publications (3)

Publication Number Publication Date
JP2002523470A JP2002523470A (ja) 2002-07-30
JP2002523470A5 true JP2002523470A5 (cg-RX-API-DMAC7.html) 2006-11-02
JP4601823B2 JP4601823B2 (ja) 2010-12-22

Family

ID=22270760

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000567236A Expired - Fee Related JP4601823B2 (ja) 1998-09-01 1999-08-31 経口ワクチン組成物

Country Status (7)

Country Link
EP (2) EP2168593A1 (cg-RX-API-DMAC7.html)
JP (1) JP4601823B2 (cg-RX-API-DMAC7.html)
AT (1) ATE452651T1 (cg-RX-API-DMAC7.html)
AU (1) AU5441199A (cg-RX-API-DMAC7.html)
CA (1) CA2341352C (cg-RX-API-DMAC7.html)
DE (1) DE69941848D1 (cg-RX-API-DMAC7.html)
WO (1) WO2000012124A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR011700A0 (en) 2000-09-14 2000-10-05 Austin Research Institute, The Composition comprising immunogenic virus sized particles (VSP)
US7998507B2 (en) 2000-09-21 2011-08-16 Elan Pharma International Ltd. Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
US6977085B2 (en) 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US6607784B2 (en) 2000-12-22 2003-08-19 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US6884436B2 (en) 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US7193084B2 (en) 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US6951656B2 (en) 2000-12-22 2005-10-04 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
MXPA04002446A (es) 2001-09-26 2004-07-23 Baxter Int Preparacion de nanoparticulas de tamano de submicras mediante dispersion y remocion de la fase liquida o solvente.
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
JP2005508939A (ja) * 2001-10-12 2005-04-07 エラン ファーマ インターナショナル,リミティド 即時放出および徐放特性を組み合わせて有する組成物
US7112340B2 (en) 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
EP1490025B1 (en) * 2002-03-20 2008-02-13 Elan Pharma International Limited Nanoparticulate compositions of map kinase inhibitors
FR2857592B1 (fr) * 2003-07-18 2006-02-24 Sod Conseils Rech Applic Nouveau procede de preparation de microparticules
US7785612B2 (en) * 2005-04-20 2010-08-31 Taiho Pharmaceutical Co., Ltd. Polyamino acid for use as adjuvant
JP4621218B2 (ja) * 2007-02-09 2011-01-26 有限会社バイオ研 Th1誘導剤及びその製造方法
WO2011026111A1 (en) * 2009-08-31 2011-03-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Oral delivery of a vaccine to the large intestine to induce mucosal immunity

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5417986A (en) 1984-03-16 1995-05-23 The United States Of America As Represented By The Secretary Of The Army Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
IL84167A (en) 1986-10-24 1991-04-15 Southern Res Inst Oral delivery of bioactive agents to and through the peyer's patch by use of microencapsulation
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
JP2743177B2 (ja) * 1987-04-24 1998-04-22 財団法人阪大微生物病研究会 百日咳菌の培養方法、及び百日咳トキソイドとその混合ワクチン
ES2080941T3 (es) * 1990-02-12 1996-02-16 Smithkline Beecham Biolog Nueva vacuna y procedimiento para la misma.
GB9209118D0 (en) * 1992-04-28 1992-06-10 Sb 120 Amsterdam Bv Vaccine compositions
DE69332031T2 (de) 1993-01-08 2002-12-19 Csl Ltd., Parkville Impfstoffpräparate
WO1995011008A2 (en) 1993-10-22 1995-04-27 Genentech, Inc. Methods and compositions for microencapsulation of adjuvants
CA2156718A1 (en) 1993-12-23 1995-06-29 Bruno Gander Immunological response potentiation process
JP3747077B2 (ja) * 1994-04-28 2006-02-22 武田薬品工業株式会社 百日咳菌由来感染防御成分の分離取得方法
ATE252894T1 (de) * 1995-01-05 2003-11-15 Univ Michigan Oberflächen-modifizierte nanopartikel und verfahren für ihre herstellung und verwendung
GB9713156D0 (en) * 1997-06-20 1997-08-27 Microbiological Res Authority Vaccines

Similar Documents

Publication Publication Date Title
JP2002523471A5 (cg-RX-API-DMAC7.html)
Leo et al. In vitro evaluation of PLA nanoparticles containing a lipophilic drug in water-soluble or insoluble form
DE60213861T2 (de) Orodispergierbare tabletten mit fexofenadin
EP1476140B1 (de) Geschmacksmaskierte film- oder oblatenförmige arzneizubereitung
US6589562B1 (en) Multicomponent biodegradable bioadhesive controlled release system for oral care products
JPH11509223A5 (cg-RX-API-DMAC7.html)
JP2002540077A5 (cg-RX-API-DMAC7.html)
CY1117889T1 (el) Πολυμερες γαλακτικου οξεος και διεργασια για την παραγωγη αυτου
JP2003533465A5 (cg-RX-API-DMAC7.html)
JP2005525403A5 (cg-RX-API-DMAC7.html)
ATE175699T1 (de) Polymer-mikrokugeln und verfahren zu deren herstellung
ATE232090T1 (de) Orale pharmazeutische zusammensetzungen die pantoprazol mit verzögerter freisetzung und antimikrobielle mittel enthalten
CA2266629A1 (en) Taste-masked microcapsule compositions and methods of manufacture
SK285999B6 (sk) Orálne aplikovateľný prípravok majúci okamžitú zmáčateľnosť a spôsob jeho výroby
KR101900482B1 (ko) 미립구형 서방출 주사제 및 그의 제조방법
JP2011037876A5 (cg-RX-API-DMAC7.html)
DE60232147D1 (de) Pharmazeutische zubereitung mit verzögerter wirkstoff-freisetzung enthaltend milchsäure-glycolsäure copolymer, und verfahren zu deren herstellung
CA2366216A1 (en) Polycationic carbohydrates as immunostimulants in vaccines
JP2018503736A5 (cg-RX-API-DMAC7.html)
ATE369124T1 (de) Hautfreundliches wirkstoffpflaster zur transdermalen verabreichung nichtsteroidaler antirheumatika
DE69900544D1 (de) Pharmazeutische zusammensetzungen in form von polymeren mikropartikeln erhalten durch extrusion und bildung von kügelchen
CA2340898A1 (en) Compositions and methods for treating intracellular infections
DE69941848D1 (de) Orale impfstoff-zusammensetzung
DE69622739D1 (de) Pharmazeutische zubereitung mit schneller freisetzung
WO1999038496A1 (en) Fast dissolving pharmaceutical products